A Phase I Study of Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
Phase of Trial: Phase I
Latest Information Update: 09 Nov 2015
At a glance
- Drugs Sorafenib (Primary) ; Temozolomide
- Indications Glioblastoma; Gliosarcoma
- Focus Adverse reactions
- 01 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 10 Sep 2012 Planned End Date changed from 1 Aug 2013 to 1 Aug 2014 as reported by ClinicalTrials.gov.
- 07 Oct 2011 Planned end date changed from 1 Aug 2012 to 1 Aug 2013 as reported by ClinicalTrials.gov.